Related Experiment Video

Updated: May 17, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Understanding resistance to targeted cancer drugs through loss of function genetic screens

Katrien Berns1, René Bernards

  • 1Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Division Molecular Carcinogenesis, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|November 13, 2012
PubMed

Insights

Cancer cells rely on specific driver mutations, but resistance develops. RNA interference screens can identify drug resistance mechanisms to develop better combination therapies for cancer treatment.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Cancer genomes reveal driver mutations conferring tumor growth and survival advantages.
  • Oncogene addiction describes tumor sensitivity to targeted inhibition of these driver pathways.
  • Targeted cancer therapies offer an alternative to traditional cytotoxic drugs.

Purpose of the Study:

  • To review the use of RNA interference functional genetic screens in identifying drug resistance mechanisms.
  • To discuss the application of this technology in developing effective combination cancer therapies.

Main Methods:

  • Utilizing RNA interference (RNAi) functional genetic screens.
  • Analyzing cancer genomes for driver mutations.
  • Investigating oncogene addiction principles.

Main Results:

  • Drug resistance, both primary and acquired, remains a significant challenge in advanced cancers.
  • Understanding resistance mechanisms is crucial for designing superior combination treatment strategies.
  • RNA interference screens offer a powerful approach to uncover clinically relevant resistance pathways.

Conclusions:

  • RNA interference screens are valuable tools for identifying cancer drug resistance mechanisms.
  • This technology can guide the development of combination therapies to overcome or prevent resistance.
  • Proactive strategies are needed to combat treatment failure in advanced human cancers.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...